The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 2, 2009, Pages 254-261

  Styn, Mindi A ^a,d   Nukui, Tomoko ^b   Romkes, Marjorie ^b   Perkins, Kenneth ^b   Land, Stephanie R ^c   Weissfeld, Joel L ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d 415 Victoria Building ^*  (United States)

Author keywords

Case control study; Dopamine; Genotype; Tobacco use cessation

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; SMOKING CESSATION;

AGED; ALLELES; CASE-CONTROL STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D2; SMOKING; SMOKING CESSATION;

NICOTIANA TABACUM;

EID: 61449265126     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30801     Document Type: Article

References (33)

1. American Cancer Society. 2003. Cancer Facts and Figures 2003. Atlanta: American Cancer Society.
2. Arinami T, Ishiguro H, Onaivi E. 2000. Polymorphisms in genes involved in neurotransmission in relation to smoking. Eur J Pharmacol 410(2-3): 215-226.
3. Blomqvist O, Gelernter J, Kranzler H. 2000. Family-based study of DRD2 alleles in alcohol and drug dependence. Am J Med Genet 96(5):659-664.
4. Brody A, Olmstead R, London E, Farahi J, Meyer J, Grossman P, Lee G, Huang J, Hahn E, Mandelkern M. 2004. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161:1211-1218.
5. Brody A, Mandelkern M, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London E, et al. 2006. Gene variants of brain dopmaine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 63:808-816.
6. CDC. 2002. Cigarette smoking among adults-United States, 2002. MMWR 51(29):642-645.
7. Comings D, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D. 1996. The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics 6(1):73-79.
8. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV. 2003. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12(3):205-216.
9. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. 2001. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenom J 1:152-156.
10. Heinz A, Goldman D, Jones D, Palmour R, Hommer D, Gorey J, Lee K, Linnoila M, Weinberger D. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2):133-139.
11. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J. 2000. Prediction of dopamine transporter binding availability by genotype: A preliminary report. Am J Psychiatry 157(10):1700-1703.
12. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, Tan X, Easteal S. 2000. Association of smoking and personality with a polymorphism of the dopmaine transporter gene: Results from a community survey. Am J Med Genet 96:331-334.
13. Kang AM, Palmatier MA, Kidd KK. 1999. Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46(2):151-160.
14. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA. 1999. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 29(2):299-308.
15. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. 1999. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18(1):14-20.
16. Lerman C, Shields PG, Wileyto EP, Audrain J, Hawk LH Jr, Pinto A, Kucharski S, Krishnan S, Niaura R, Epstein LH. 2003. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol 22(5):541-548.
17. Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, et al. 2006. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: Results of two randomized clinical trials. Neuropsychopharmacology 31:231-242.
18. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. 2001. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79(5):1033-1038.
19. Morton L, Wang S, Bergen A, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes R, Chanock S, Caporaso N. 2006. DRD2 genetic variation in relation to smoking and obesity in the prostate, lung, colorectal, and ovarian cancer screening trial. Pharmacogenet Genom 16:901-910.
20. Neville MJ, Johnstone EC, Walton RT. 2004. Identification and characterization of ANK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23(6):540-545.
21. Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS. 1994. D2 dopamine receptor gene and cigarette smoking: A reward gene? Med Hypotheses 42(4):257-260.
22. Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD, Chen TTL, Cinciripini PM. 2007. The DRD2 TaqIB polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogenom J 7:266-274.
23. Rossing MA. 1998. Genetic influences on smoking: Candidate genes. Environ Health Perspect 106(5):231-238.
24. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FRt, et al. 1999. A genetic association for cigarette smoking behavior. Health Psychol 18(1):7-13.
25. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, et al. 1998. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90(5):358-363.
26. SRNT Subcommittee on Biochemical Verification. 2002. Biochemical verification of tobacco use and cessation. Nicotine Tobacco Res 4(2):149-159.
27. Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T. 2005. Dopamine receptor DRD2 genotype and smoking cessation outcomes following treatment with bupropion SR. Pharmacogenom J 5:21-29.
28. Timberlake D, Haberstick B, Lessem J, Smolen A, Ehringer M, Hewitt J, Hopfer C. 2006. An association between the DAT1 polymorphism and smoking behavior in young adults from the national longitudinal study of adolescent health. Health Psychol 25(2):190-1907.
29. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, Eisen SA, Lyons MJ, Goldberg J, Tsuang M. 1999. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56(7):655-661.
30. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB. 2005. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46:745-751.
31. Vandenbergh DJ, Bennett CJ, Grant MD, Strasser AA, O'Connor R, Stauffer RL, Vogler GP, Kozlowski LT. 2002. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: Failure to replicate and finding that never-smokers may be different [see comment]. Nicotine Tobacco Res 4(3):333-340.
32. Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR. 2000. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: A lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 9(10):1021-1026.
33. Yoshida K, Hamajima N, Kozaki K, Saito H, Maeno K, Sugiura T, Ookuma K, Takahashi T. 2001. Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol Biomarkers Prev 10(4):403-405.